Skip to main content

Table 4 The between group difference in biochemical end-points

From: Functional training added to intradialytic cycling lowers low-density lipoprotein cholesterol and improves dialysis adequacy: a randomized controlled trial

 

8th week

16th week

Variable

Difference (95% CI)

p-value (INT-CON)

Difference (95% CI)

p-value (INT-CON)

Albumin (g/L)

−0.48 ± 0.73 (− 1.97 to 1.02)

0.520

−0.18 ± 0.66 (− 1.51 to 1.16)

0.79

Cholesterol (mmol/L)

− 0.11 ± 0.17 (− 0.46 to 0.26)

0.574

−0.23 ± 0.24 (− 0.71 to 0.25)

0.34

LDL (mmol/L)

−0.16 ± 0.16 (− 0.48 to 0.17)

0.339

−0.35 ± 0.16 (− 0.68 to − 0.03)

0.03*

HDL (mmol/L)

−0.03 ± 0.06 (− 0.15 to 0.09)

0.611

−0.05 ± 0.08 (− 0.22 to 0.11)

0.51

TG (mmol/L)

0.12 ± 0.19 (− 0.28 to 0.52)

0.537

0.56 ± 0.33 (− 0.12 to 1.24)

0.11

CRP (mg/L)

0.53 ± 0.71 (− 0.93 to 1.98)

0.464

− 1.18 ± 2.03 (− 5.35 to 2.99)

0.57

Hemoglobin (g/L)

0.84 ± 4.84 (− 9.03 to 10.72)

0.863

−0.84 ± 4.12 (− 9.24 to 7.56)

0.84

  1. Note: Values are expressed as adjusted mean difference ± standard deviation using ANCOVA – analysis of covariance with adjustment for baseline values. All significant between-group differences with ANCOVA adjusted test were also significant with unadjusted between-group ANOVA test (p < 0.05). Abbreviations: INT intervention group, CON control group, LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, TG triglycerides, CRP C-reactive protein, Kt/V dialysis adequacy, ANCOVA analysis of covariance, CI confidence interval; *, p < 0.05
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us